InformedCitizen.usBeta
In committeeHealth care

Equity in STI Testing Act

H.R. 9946 · House bill · Introduced July 23, 2026

The Equity in STI Testing Act would cover testing for certain sexually transmitted infections without patient costs for people in specified federal health programs.

At a glance

Who it affects

  • People enrolled in Medicare Advantage, Medicaid, or CHIP
  • People covered by TRICARE
  • People receiving Department of Veterans Affairs health benefits
  • People receiving Indian Health Service care

Where it stands

In committee

Lobbying and money

No lobbying reported yet

Lobbyists report every three months, about 20 days after each quarter ends. We have January 2025 through September 2026 reports. Newer reports will be added once filed and published.

What it would do

Written with AI from the official summary by Congress's research office.

How South Carolina voted

No recorded roll-call vote on this bill yet.

Groups that lobbied on it and gave to SC's members

PAC, lobbyist campaign and qualifying employee money this election, shown separately and never added together. Lobbying reports name the bills a group worked on, not which side it took.

No lobbying reported yet. Lobbyists report every three months, about 20 days after each quarter ends. We have January 2025 through September 2026 reports. Newer reports will be added once filed and published.

Official record

Official title, sponsor and status
Official title
To require the coverage of testing for certain sexually transmitted infections without the imposition of cost-sharing, and for other purposes.
Sponsor
Rep. Williams, Nikema (D-GA)
Introduced
July 23, 2026
Cosponsors
11
Committees
House Veterans' Affairs Committee; House Natural Resources Committee; House Armed Services Committee; House Ways and Means Committee; House Energy and Commerce Committee
Latest action
July 30, 2026 · Referred to the Subcommittee on Health.
Congress.gov ↗
Official summary from the Congressional Research Service

Equity in STI Testing Act This bill provides for coverage, without cost-sharing, of testing for certain sexually transmitted infections under Medicare Advantage, Medicaid, the Children's Health Insurance Program (CHIP), TRICARE, Department of Veterans Affairs health benefits, and the Indian Health Service.

Summary on Congress.gov ↗
Everyone who lobbied on this bill (0 groups)

No lobbying report we have loaded names this bill. That doesn't mean no lobbying took place.

Lobbyists report every three months, about 20 days after each quarter ends. We have January 2025 through September 2026 reports. Newer reports will be added once filed and published. Reports for October through December 2026 are due January 20, 2027.